Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1996
08/29/1996WO1996019578A3 METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN ahpCF OPERON
08/29/1996WO1996018741A3 Liposome-mediated transfection of central nervous system cells
08/29/1996WO1996017927A3 Reporter cell line
08/29/1996WO1996017869A3 Interleukin-6 (il-6) antagonists
08/29/1996WO1996017074A3 Rna polymerase ii peptides and methods of use
08/29/1996WO1996017059A3 Receptor for cell-binding domain of thrombospondins
08/29/1996WO1996014873A3 COVALENTLY BOUND β-GLUCAN CONJUGATES IN TARGETED DELIVERY
08/29/1996WO1996014412A3 cDNA ENCODING A BMP TYPE II RECEPTOR
08/29/1996DE19539130A1 Mittel zur Therapie von Tumoren und anderen Hyperplasien Means for the therapy of tumors and other hyperplasias
08/29/1996DE19506669A1 Lipoxygenase inhibitor for treating asthma, tumours, shock etc.
08/29/1996DE19506610A1 New orally active thrombin inhibiting peptide cpds.
08/29/1996DE19506362A1 Prodn. of cytokine mixt. for use in cancer therapy
08/29/1996CA2566828A1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm)
08/29/1996CA2213610A1 Ingap protein involved in pancreatic islet neogenesis
08/29/1996CA2213484A1 Modulators of regulatory proteins
08/29/1996CA2213481A1 Compositions and methods for enhancing the growth of hair and restoring hair color
08/29/1996CA2213469A1 Novel osteoclastogenesis inhibitory factor and methods for producing same
08/29/1996CA2213439A1 Methods and compositions for administering gene therapy vectors
08/29/1996CA2213417A1 Novel cationic lipids and the use thereof
08/29/1996CA2213337A1 Isolated nonapeptides presented by hla molecules, and uses thereof
08/29/1996CA2213135A1 2,6-diaryl pyridazinones with immunosuppressant activity
08/29/1996CA2212870A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
08/29/1996CA2211541A1 Isoforms of human interleukin-1.beta. converting enzyme and methods of using the same
08/29/1996CA2211435A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins
08/29/1996CA2210320A1 Compounds for preventing multidrug resistance in cancer cells containing protein kinase inhibitors
08/29/1996CA2197675A1 Transgenically produced antithrombin iii
08/28/1996EP0728764A1 Peptide capable of inducing immune response against hiv and aids preventive or remedy containing the peptide
08/28/1996EP0728746A1 Azepinone compounds useful in the inhibition of ACE and NEP
08/28/1996EP0728484A1 Use of magnesium vanadate for the treatment of insulin resistance syndrome
08/28/1996EP0728481A2 Use of quinoxaline and protease inhibitors in a composition for the treatment of AIDS and/or HIV infections
08/28/1996EP0728477A2 Compositions for topical administration of pharmaceutically active agents
08/28/1996EP0728210A1 Thrombin mutants
08/28/1996EP0728209A1 Endothelin-converting enzyme
08/28/1996EP0728207A1 Telomerase activity assays
08/28/1996EP0728206A1 Alteration of sequence of a target molecule
08/28/1996EP0728205A1 Method and reagent for treatment of arthritic conditions
08/28/1996EP0728203A1 Analogous peptides of the internal image of a viral protein
08/28/1996EP0728202A1 Episomal expression vector for human gene therapy
08/28/1996EP0728200A1 Haemophilus transferrin receptor genes
08/28/1996EP0728194A1 $i(IN SITU) MODIFICATION AND MANIPULATION OF STEM CELLS OF THE CENTRAL NERVOUS SYSTEM
08/28/1996EP0728148A1 Improved immunogenic compositions against human gastrin 17
08/28/1996EP0728147A1 Receptor specific atrial natriuretic peptides
08/28/1996EP0728146A1 Conotoxin peptides
08/28/1996EP0728145A1 Endothelin receptor antagonists
08/28/1996EP0728144A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
08/28/1996EP0728143A1 Oncoprotein protein kinase
08/28/1996EP0728142A1 Novel antler-derived bone growth factors
08/28/1996EP0728018A1 Therapy
08/28/1996EP0728017A1 Treatment of bacterially-induced inflammatory diseases
08/28/1996EP0728016A1 Use of anti-idiotypic antibodies to prevent hyperacute rejection of xenografts
08/28/1996EP0728013A1 Compositions and method for stimulating antibody release by b lymphocytes
08/28/1996EP0728012A1 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF
08/28/1996EP0728011A1 Growth factor compositions, preparation and use
08/28/1996EP0728010A1 Method for treating hepatitis b carriers with minimal disease
08/28/1996EP0728005A1 Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide
08/28/1996EP0717736A4 Polar-substituted hydrocarbons
08/28/1996EP0621862B1 Organic salts of n, n'-diacetyl cystine
08/28/1996EP0571407B1 Cloning of a new member of the fibroblast growth factor (fgf) receptor family
08/28/1996EP0536226B1 The combination of growth hormone and insulin-like growth factor-i enhances growth
08/28/1996EP0406297B1 Medical use of neuropeptide Antagonist G
08/28/1996EP0313578B1 Novel osteoinductive compositions
08/28/1996EP0305387B2 Insulinotropic hormone
08/28/1996CN1129984A Immunoassay for soluble fibrin polymers
08/28/1996CN1129955A A truncated keratinocyte growth factor (KGF) having increased biological activity
08/28/1996CN1129947A Polymeric matrices and their uses in pharmaceutical compositions
08/28/1996CN1129944A Novel protein and process for producing the same
08/28/1996CN1129904A Therapeutic preparation for inhalation
08/28/1996CN1129737A Modified protein for gene transfer and process for producing the same
08/28/1996CA2170222A1 Use of quinoxalines in combination with protease inhibitors as medicaments for treating aids and/or hiv infections
08/27/1996US5550316 Transgenic animal model system for human cutaneous melanoma
08/27/1996US5550262 Treatment of muscles wasting diseases
08/27/1996US5550216 Gelatinase A inhibitor, and analytical reagent thereof for the determination of gelatinase A
08/27/1996US5550214 Isolated antigenic oncogene peptide fragments and uses
08/27/1996US5550213 Inhibitors of urokinase plasminogen activator
08/27/1996US5550212 Analogues of hGH-RH(1-29)NH2 having antagonistic activity
08/27/1996US5550188 Polymer conjugates ophthalmic devices comprising collagen-polymer conjugates
08/27/1996US5550183 Metal-peptide compositions and methods for stimulating hair growth
08/27/1996US5550159 Peptide mimics useful as platelet aggregation inhibitors
08/27/1996US5550131 2-piperazinone compounds and their use
08/27/1996US5550127 Administering angiotensin converting enzyme inhibitor to treat exercise-induced pulmonary hemorrhage in non-human mammals
08/27/1996US5550114 Infecting host kidney cells with fibroma virus, disrupting cells, filtering, adding methanol, centrifuging to remove precipitate, collecting epidermal growth factor inhibitor
08/27/1996US5550110 Pentapeptide and hexapeptide analogs of endothelin-1
08/27/1996US5550109 Having antimicrobial, antifungal activity
08/27/1996US5550108 Adding an 18 kda c5b-9 inhibitory protein to prevent platelet and endothelial cell activation
08/27/1996US5550107 Anticarcinogenic agents and antiestrogens
08/27/1996US5550055 Recombinant DNA-produced T11 and fragments thereof
08/27/1996US5550052 Useful for detection of lav antibodies in human sera
08/27/1996US5550050 Exposing cells enclosed in biocompatible capsules to restrictive environmental conditions which match those which will be encountered after implantation until desired responses are established
08/27/1996US5550049 Useful as insecticides and arachnicidic agents
08/27/1996US5550042 Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the same
08/27/1996US5550039 Oligonucleotide primers for HLA class I B locus DNA typing
08/27/1996US5550037 Dna clones
08/27/1996US5550034 Apolipoprotein B mRNA editing protein compositions and methods
08/27/1996US5550023 Amplification of human MDM2 gene in human tumors
08/27/1996US5550019 Methods of identifying compounds which alter apoptosis
08/27/1996US5550017 Anti-paramyxovirus screening method and vaccine
08/27/1996US5549904 Tissue transglutaminase in pharmaceutically acceptable carrier; promotes adhesion upon treatment of tissue in presence of divalent metal ion
08/27/1996US5549899 Culture product of strain of giardia lamblia and an adjuvant, used to treat intestinal protozoal infections in canine and feline species
08/27/1996US5549894 Disinfecton formulations and methods using D-enantiomeric anti-microbial peptides
08/27/1996US5549893 Use of protein C in the treatment of purpura fulminans
1 ... 2770 2771 2772 2773 2774 2775 2776 2777 2778 2779 2780 2781 2782 2783 2784 2785 2786 2787 2788 2789 2790 ... 3163